BENITEC BIOPHARMA INC - COM (BNTC)

CUSIP: 08205P100

Q1 2023 13F Holders as of 31 Mar 2023

Share change
-674,190
SEC-reported price per share
$0.21
Number of holders
20
Value change
-$135,580
Number of buys
3
Number of sells
11

Security key

08205P100

Report period

Q1 2023

Institutions

20

Top holders

10

Ownership snapshot

Top reported holders of BNTC - BENITEC BIOPHARMA INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Steven Michael Oliveira
Disclosed value leader
Steven Michael Oliveira
Comparable rows
0/15
Latest evidence
31 Dec 2022
3/4/5 13F Highest disclosed value: $3,044,300 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Steven Michael Oliveira has the largest disclosed position value at $3.04M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Steven Michael Oliveira's linked filing trail.
Disclosed position value Top 5
Steven Michael Oliveira $3.04M
FRANKLIN TEMPLETON INC $1.7M
MONTANOVA CAPITAL, LLC $130.7K
RENAISSANCE TECHNOLOGIES LLC $64K
MORGAN STANLEY $62.7K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Steven Michael Oliveira
3/4/5
10%+ Owner
—
denominator unverified
$3,044,300
1,000,000 shares
— 28 Apr 2021
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$1,700,000
10,000,000 shares
— 31 Dec 2022
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$130,730
769,000 shares
— 31 Dec 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$64,000
375,531 shares
— 31 Dec 2022
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$62,717
368,923 shares
— 31 Dec 2022
Walleye Capital LLC
13F
Company
13F
—
denominator unverified
$58,483
344,015 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
20
Shares
11,633,366
Rows available
20
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
20
Q1 2023 holders
20
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .